Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 4.2 USD 0.48% Market Closed
Market Cap: 4.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Intrinsic Value

PRTG's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one PRTG stock under the Base Case scenario is 3.84 USD. Compared to the current market price of 4.2 USD, Portage Biotech Inc is Overvalued by 9%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PRTG Intrinsic Value
3.84 USD
Overvaluation 9%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Portage Biotech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PRTG cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PRTG?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Biotechnology Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Portage Biotech Inc

Provide an overview of the primary business activities
of Portage Biotech Inc.

What unique competitive advantages
does Portage Biotech Inc hold over its rivals?

What risks and challenges
does Portage Biotech Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Portage Biotech Inc.

Provide P/S
for Portage Biotech Inc.

Provide P/E
for Portage Biotech Inc.

Provide P/OCF
for Portage Biotech Inc.

Provide P/FCFE
for Portage Biotech Inc.

Provide P/B
for Portage Biotech Inc.

Provide EV/S
for Portage Biotech Inc.

Provide EV/GP
for Portage Biotech Inc.

Provide EV/EBITDA
for Portage Biotech Inc.

Provide EV/EBIT
for Portage Biotech Inc.

Provide EV/OCF
for Portage Biotech Inc.

Provide EV/FCFF
for Portage Biotech Inc.

Provide EV/IC
for Portage Biotech Inc.

Show me price targets
for Portage Biotech Inc made by professional analysts.

What are the Revenue projections
for Portage Biotech Inc?

How accurate were the past Revenue estimates
for Portage Biotech Inc?

What are the Net Income projections
for Portage Biotech Inc?

How accurate were the past Net Income estimates
for Portage Biotech Inc?

What are the EPS projections
for Portage Biotech Inc?

How accurate were the past EPS estimates
for Portage Biotech Inc?

What are the EBIT projections
for Portage Biotech Inc?

How accurate were the past EBIT estimates
for Portage Biotech Inc?

Compare the revenue forecasts
for Portage Biotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Portage Biotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Portage Biotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Portage Biotech Inc compared to its peers.

Compare the P/E ratios
of Portage Biotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Portage Biotech Inc with its peers.

Analyze the financial leverage
of Portage Biotech Inc compared to its main competitors.

Show all profitability ratios
for Portage Biotech Inc.

Provide ROE
for Portage Biotech Inc.

Provide ROA
for Portage Biotech Inc.

Provide ROIC
for Portage Biotech Inc.

Provide ROCE
for Portage Biotech Inc.

Provide Gross Margin
for Portage Biotech Inc.

Provide Operating Margin
for Portage Biotech Inc.

Provide Net Margin
for Portage Biotech Inc.

Provide FCF Margin
for Portage Biotech Inc.

Show all solvency ratios
for Portage Biotech Inc.

Provide D/E Ratio
for Portage Biotech Inc.

Provide D/A Ratio
for Portage Biotech Inc.

Provide Interest Coverage Ratio
for Portage Biotech Inc.

Provide Altman Z-Score Ratio
for Portage Biotech Inc.

Provide Quick Ratio
for Portage Biotech Inc.

Provide Current Ratio
for Portage Biotech Inc.

Provide Cash Ratio
for Portage Biotech Inc.

What is the historical Revenue growth
over the last 5 years for Portage Biotech Inc?

What is the historical Net Income growth
over the last 5 years for Portage Biotech Inc?

What is the current Free Cash Flow
of Portage Biotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Portage Biotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Portage Biotech Inc

Current Assets 5.2m
Cash & Short-Term Investments 3.3m
Receivables 86k
Other Current Assets 1.8m
Non-Current Assets 41k
PP&E 27k
Other Non-Current Assets 14k
Current Liabilities 3m
Accounts Payable 1.5m
Accrued Liabilities 1.3m
Other Current Liabilities 211k
Non-Current Liabilities -279k
Other Non-Current Liabilities -279k
Efficiency

Earnings Waterfall
Portage Biotech Inc

Revenue
0 USD
Operating Expenses
-98.8m USD
Operating Income
-98.8m USD
Other Expenses
27.7m USD
Net Income
-71.1m USD

Free Cash Flow Analysis
Portage Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PRTG Profitability Score
Profitability Due Diligence

Portage Biotech Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Portage Biotech Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

PRTG Solvency Score
Solvency Due Diligence

Portage Biotech Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
39/100
Solvency
Score

Portage Biotech Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PRTG Price Targets Summary
Portage Biotech Inc

There are no price targets for PRTG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PRTG?

Click here to dive deeper.

Dividends

Portage Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PRTG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Portage Biotech Inc Logo
Portage Biotech Inc

Country

Canada

Industry

Biotechnology

Market Cap

4.4m USD

Dividend Yield

0%

Description

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. The company is headquartered in Toronto, Ontario and currently employs 6 full-time employees. The company went IPO on 2013-10-28. The firm is advancing therapies to improve long-term treatment response and quality of life in patients with evasive cancers. The Company’s access to technologies coupled with a deep understanding of biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of six diverse platforms, with programs including invariant natural killer T cell (iNKT) agonists, which includes PORT-2 and PORT-3, therapies that activate the innate and adaptive immune system. Its portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent of targeting the adenosine pathway. Within these six platforms, the Company has 14 products in development with multiple clinical readouts.

Contact

ONTARIO
TORONTO
47 Avenue Rd Suite 200
+14169291806.0
portagebiotech.com

IPO

2013-10-28

Employees

6

Officers

CEO & Chairman of Board
Dr. Ian B. Walters M.B.A., M.D.
Chief Scientific Officer
Dr. Robert A. Kramer Ph.D.
Chief Business Officer
Mr. Brian Wiley
Chief Financial Officer
Ms. Eun-Jae Park CPA
Controller
Adam Melero

See Also

Discover More
What is the Intrinsic Value of one PRTG stock?

The intrinsic value of one PRTG stock under the Base Case scenario is 3.84 USD.

Is PRTG stock undervalued or overvalued?

Compared to the current market price of 4.2 USD, Portage Biotech Inc is Overvalued by 9%.

Back to Top